Table 7.
The top 10 most frequently cited references.
| Rank | Title | Citations | Journal | JCR | IF | DOI |
|---|---|---|---|---|---|---|
| 1 | Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | 160 | New England journal of medicine | Q1 | 96.2 | 10.1056/nejmoa043330 |
| 2 | Hallmarks of cancer: the next generation | 128 | Cell | Q1 | 45.5 | 10.1016/j.cell.2011.02.013 |
| 3 | Understanding the Warburg effect: the metabolic requirements of cell proliferation | 120 | Science | Q1 | 44.7 | 10.1126/science.1160809 |
| 4 | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | 102 | Cancer Cell | Q1 | 48.8 | 10.1016/j.ccr.2009.12.020 |
| 5 | The somatic genomic landscape of glioblastoma | 89 | Cell | Q1 | 45.5 | 10.1016/j.cell.2013.09.034 |
| 6 | On the origin of cancer cells | 84 | Science | Q1 | 44.7 | 10.1126/science.123.3191.309 |
| 7 | Comprehensive genomic characterization defines human glioblastoma genes and core pathways | 74 | Nature | Q1 | 50.5 | 10.1038/nature07385 |
| 8 | The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A Summary | 72 | Acta Neurochirurgica | Q3 | 1.9 | 10.1007/s00401-016-1545-1 |
| 9 | Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial | 71 | Lancet Oncology | Q1 | 41.6 | 10.1016/s1470-2045(09)70025-7 |
| 10 | Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo | 69 | Cell Metabolism | Q1 | 27.7 | 10.1016/j.cmet.2012.05.001 |